Specifically, PSME2 upregulation was evident in BRCA, LUAD, HNSC, LUSC, and STAD tumors of the C2 subtype, suggesting a functional relationship between this gene and IFN-γ signaling activity. The gene discussed is IFNG; the disease is gastric adenocarcinoma.